| Product |
CAS |
Molecular formula |
More |
| Oxazolidine, 5-(chloromethyl)-2-phenyl-(9ci) |
69157-36-4 |
C10H12ClNO |
More |
| Piperazine, 1-acetyl-3-methyl-, (3s)-(9ci) |
612493-89-7 |
|
More |
| Oxazolidine, 5-(methoxymethyl)-2-(1-methylethyl)-(9ci) |
205173-30-4 |
|
More |
| Piperazine, 1-acetyl-4-(1-methylethyl)-(9ci) |
91086-20-3 |
C9H18N2O |
More |
| Oxazolidine,3-amino-2-imino-(7ci) |
856788-14-2 |
C3H7N3O |
More |
| Piperazine, 1-acetyl-4-(1-oxo-2-propenyl)-(9ci) |
635682-61-0 |
C9H14N2O2 |
More |
| Piperazine, 1-acetyl-4-(2-methyl-2-butenyl)-(9ci) |
416893-44-2 |
|
More |
| Oxazolo[2,3-a]isoindol-5(9bh)-one, 3-ethyl-2,3-dihydro-, (3r,9bs)-(9ci |
467250-76-6 |
|
More |
| Oxazolo[2,3-a]isoindol-5(9bh)-one, 3-ethyl-2,3-dihydro-, (3s,9br)-(9ci |
467250-77-7 |
|
More |
| Piperazine, 1-acetyl-4-(2-propenyl)-(9ci) |
727721-54-2 |
C9H16N2O |
More |
| Oxazolo[2,3-a]isoindol-5(9bh)-one, 9b-ethoxy-2,3-dihydro-(9ci) |
183969-33-7 |
C12H13NO3 |
More |
| Piperazine, 1-acetyl-4-[[4-[(cyclopropylamino)sulfonyl]phenyl]sulfonyl |
604761-87-7 |
C15H21N3O5S2 |
More |
| Oxazolo[2,3-i]purin-5-amine, 7,8-dihydro- |
733714-60-8 |
C7H7N5O |
More |
| Piperazine, 1-acetyl-4-[[4-[(dimethylamino)sulfonyl]phenyl]sulfonyl]-( |
604761-90-2 |
C14H21N3O5S2 |
More |
| Oxazolo[3,2:1,2]imidazo[4,5-b]pyrazine (9ci) |
384850-76-4 |
C7H4N4O |
More |
| Piperazine, 1-acetyl-4-[3-(4-chlorophenyl)isothiazolo[4,5-d]pyrimidin- |
604741-49-3 |
|
More |
| Oxazolo[3,2-a][1,3]diazepine (9ci) |
105066-62-4 |
C7H6N2O |
More |
| Piperazine, 1-acetyl-4-[3-(4-fluorophenyl)isothiazolo[4,5-d]pyrimidin- |
604741-35-7 |
|
More |
| Oxazolo[3,2-a]benzimidazol-6-ol, 2-methyl-(9ci) |
79221-12-8 |
C10H8N2O2 |
More |
| Piperazine, 1-acetyl-4-[3-(4-methoxyphenyl)isothiazolo[4,5-d]pyrimidin |
604741-44-8 |
C18H19N5O2S |
More |
